GB Meka
Stocks to watch

RVMD

Compare

Revolution Medicines Inc · Healthcare

$205.26
▲ 0.4%Close 2026-09-30

Live intraday price

Compare with our price levels

T2220.34
T1213.00
E1188.18
E3165.82
SL158.35

Close 2026-09-30: $205.26 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 8.3% · 1 whale recently bought

1 month
▼ 0.2%
3 months
▲ 9.5%
1 year
▲ 345.5%
Analyst target
$253.92 +23.7%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$188.18 -8.3%
E2$177.04 -13.8%
E3$165.82 -19.2%
Targets
T1$213.00 3.8%
T2$220.34 7.3%
T3$224.31 9.3%
Stop-loss
SL$158.35 -22.9%
Whale cost ~$98.46 -52.0%

Risk : reward 1 : 2.3Moves ~$7.48 a day

⚖️ Positives and risks

✓ Positives (6)
  • ●1 whale bought or added last quarter
  • ●Long-term uptrend (above a rising MA200)
  • ●MACD just crossed up (momentum turning positive)
  • ●Beat the market (S&P 500) by +93% over 6 months
  • ●Average analyst price target 253.92 (upside +24%, 22 analysts)
  • ●Most analysts rate it Strong Buy
! Risks (1)
  • ●Price is +42% above MA200 — already ran a lot

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Mancini Anthony · Officer

2026-09-25 · 3,121 shares @ $200.54 · pre-planned sale (10b5-1)

$625,885
Sell

Cislini Jeff · Officer

2026-09-25 · 765 shares @ $207.32 · pre-planned sale (10b5-1)

$158,600
Sell

Mancini Anthony · Officer

2026-09-24 · 587 shares @ $200.00 · pre-planned sale (10b5-1)

$117,400
Sell

ANDERSON ELIZABETH M · Director

2026-09-22 · 4,985 shares @ $192.54 · pre-planned sale (10b5-1)

$959,805
Sell

ANDERSON ELIZABETH M · Director

2026-09-22 · 2,648 shares @ $193.44 · pre-planned sale (10b5-1)

$512,227
Sell

ANDERSON ELIZABETH M · Director

2026-09-22 · 1,500 shares @ $194.59 · pre-planned sale (10b5-1)

$291,883
Sell

ANDERSON ELIZABETH M · Director

2026-09-22 · 910 shares @ $191.85 · pre-planned sale (10b5-1)

$174,585
Sell

ANDERSON ELIZABETH M · Director

2026-09-22 · 100 shares @ $195.15 · pre-planned sale (10b5-1)

$19,515
Sell

Mancini Anthony · Officer

2026-09-18 · 1,764 shares @ $196.94 · pre-planned sale (10b5-1)

$347,402
Sell

GOLDSMITH MARK A · Director

2026-09-16 · 13,775 shares @ $199.30 · pre-planned sale (10b5-1)

$3M
Sell

Kelsey Stephen Michael · Officer

2026-09-16 · 5,484 shares @ $199.30 · pre-planned sale (10b5-1)

$1M
Sell

Horn Margaret A · COO

2026-09-16 · 4,891 shares @ $199.30 · pre-planned sale (10b5-1)

$974,792
Sell

Anders Jack · CFO

2026-09-16 · 3,992 shares @ $199.30 · pre-planned sale (10b5-1)

$795,618
Sell

Cislini Jeff · Officer

2026-09-16 · 3,314 shares @ $199.30 · pre-planned sale (10b5-1)

$660,491
Sell

Mancini Anthony · Officer

2026-09-16 · 1,747 shares @ $199.30 · pre-planned sale (10b5-1)

$348,183

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$43.9B
Next earnings2026-11-04
P/E (price to earnings)-
Forward P/E (on expected earnings)-33.5
Revenue growth (YoY)-
Earnings growth (YoY)-
Net profit margin0.0%
ROE-79.1%
Debt to equity (D/E)46%
Dividend yield-
Analyst targets (high / low)$320.00 / $179.00
Number of analysts22
Trend and technical indicators
Trend short / mid / longSideways → · Uptrend ↗ · Uptrend ↗
RSI54
MA50 / MA200$201.57 / $144.66
Distance from MA200+41.9%
MACDJust crossed up
1-year high / low$224.31 / $45.49
vs. S&P 500 (6 months)+93.2%
Volume vs. average0.91×